GWICTIC: NAC Mechanistic Study in Gulf War Veterans
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- Nova Southeastern University
- Study ID
- NCT04987775
- Phase
- EARLY_PHASE1
- Status
- Recruiting
Conditions
- Gulf War Syndrome
Eligibility Criteria
- Sex
- ALL
- Age
- 47 Years - 70 Years
- Healthy Volunteers
- Not accepted
Interventions
- N-Acetyl Cysteine — DRUG900mg 2x daily
- Placebo — DRUGMatching placebo bid
Study Details
This mechanistic study will test if NAC affects chronic oxidative stress and depletion of antioxidants in GWI participants. Blood specimen collection and neuroimaging will be used to determine whether NAC affects serum glutathione (GSH) concentration and oxidative stress in the CNS when compared to placebo.
Key Dates
- Start date
- Nov 30, 2023
- Status verified
- Jul 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 170 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: N-Acetyl Cysteine (NAC)Participants who are randomized to the intervention arm will receive N-Acetyl-L-Cysteine (Free-Form/NAC) 900mg two times a day for 8 weeks after the initiation of the first dose of study drug.
- Placebo Comparator: PlaceboParticipants who are randomized to the placebo arm will take matching placebo two times a day for 8 weeks after the initiation of the first dose of study drug.
Primary Outcome Measure
Assess glutathione levels [ Time Frame: Baseline to 8 weeks ]
Central Contacts
- Nancy Klimas, MD9542622855
- Karen Kesler, PhD
Locations (7)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| VA Palo Alto Health Care System War Related Illness and Injury Study Center | Palo Alto | California | 94304 | Wes Ashford, MD (PRINCIPAL_INVESTIGATOR) |
| Nova Southeastern University | Fort Lauderdale | Florida | 33314 | Nancy Klimas, MD Amaanpreet Cheema, PhD Nancy Klimas, MD (PRINCIPAL_INVESTIGATOR) Amaanpreet Cheema, PhD (SUB_INVESTIGATOR) |
| Boston University Medical School | Boston | Massachusetts | 02215 | - |
| VA New Jersey Health Care System War Related Illness and Injury Study Center | East Orange | New Jersey | 07018 | Helena Chandler, PhD (PRINCIPAL_INVESTIGATOR) |
| Weill Cornell Medical College | New York | New York | 10021 | - |
| RTI International | Durham | North Carolina | 27709 | - |
| Michael E. DeBakey VA Medical Center | Houston | Texas | 77030 | Drew Helmer, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Palo Alto, CA
By research site
VA Palo Alto Health Care System War Related Illness and Injury Study Center· Palo Alto, CANova Southeastern University· Fort Lauderdale, FLBoston University Medical School· Boston, MAVA New Jersey Health Care System War Related Illness and Injury Study Center· East Orange, NJWeill Cornell Medical College· New York, NYRTI International· Durham, NC
Related Studies
- Growth Hormone Replacement in Veterans With GWI and AGHD (GWIT)PHASE2 · Recruiting · Baylor College of Medicine · Houston, Texas
- Confirmation of Diet as a Treatment for Gulf War IllnessPHASE3 · Recruiting · American University · Washington D.C., District of Columbia
- Validating Gulf War Illness Blood BiomarkersRecruiting · Roskamp Institute Inc. · Palo Alto, California
- Clinical Evaluation of Montelukast in Veterans With Gulf War IllnessPHASE1 · Recruiting · Baylor College of Medicine · Houston, Texas